Harnessing Liquid Biopsies to Transform Cancer Treatment Selection, Monitoring & Early Detection & Empower Precision Treatments
Time: 8:00 am
day: Day One
Details:
- Reviewing current and future liquid biopsy assay use in cancer care, including early detection and molecular residual disease
- Discussing recent collaborative frameworks and standards for best practices in liquid biopsy assay validation
- Enabling broad access to liquid biopsy assays and global harmonization of regulatory requirements
- Looking at what’s on the horizon: emerging trends in liquid biopsy assay development
